In a 16‑year‑old female with 13 days of intermittent fever, recent non‑productive cough, seven loose yellow non‑bloody stools positive for Entamoeba histolytica, icteric sclerae, markedly elevated AST and ALT, indirect hyperbilirubinemia, mild anemia, thrombocytopenia, and urine containing numerous pus cells and bacteria, what are the likely diagnoses and differentials, and what management and further work‑up are recommended?

Acute Hepatitis with Amebiasis and Possible Urinary Tract Infection

This patient most likely has acute viral or drug-induced hepatitis as the primary diagnosis, with concurrent intestinal amebiasis and a possible urinary tract infection requiring immediate treatment with metronidazole for the amebiasis and antibiotics for the UTI, while discontinuing the current broad-spectrum antibiotics that are not indicated.

Primary Diagnosis: Acute Hepatitis (Most Likely Viral or Drug-Induced)

The markedly elevated transaminases (SGOT 537, SGPT 158) with indirect hyperbilirubinemia (indirect 1.8, direct 0.5) and icteric sclerae point to acute hepatitis as the dominant pathology. The AST:ALT ratio >3:1 with very high absolute values, combined with elevated alkaline phosphatase (377), suggests hepatocellular injury rather than cholestatic disease.

Key diagnostic considerations:

• Dengue-associated hepatitis: Positive dengue IgG indicates past infection, but negative IgM rules out acute dengue as the cause
• Acute viral hepatitis: HAV and HBV are negative, but hepatitis E has not been tested and should be the next priority given the clinical picture
• Drug-induced liver injury: Paracetamol use for 6 days could contribute, though levels are not in the toxic range
• Epstein-Barr virus (EBV) or cytomegalovirus (CMV): Common causes of hepatitis in adolescents that have not been tested

The low procalcitonin (0.12) and CRP (<5.0) essentially rule out bacterial sepsis or severe bacterial infection as the primary driver of this illness 1.

Secondary Diagnosis: Intestinal Amebiasis

The fecalysis showing Entamoeba histolytica requires treatment regardless of whether it's causing the diarrhea. However, the clinical presentation (non-bloody, yellowish diarrhea without abdominal pain) is atypical for invasive amebiasis 2, 3. The 2017 IDSA guidelines note that bloody diarrhea with fever and cramps suggests invasive disease 1.

Treatment for amebiasis:

• Metronidazole 500 mg three times daily for 7-10 days (or tinidazole 2g daily for 3 days) 3, 4
• Followed by a luminal agent: Paromomycin 30 mg/kg/day in three divided doses for 7 days to prevent relapse 3, 4

The positive stool finding mandates treatment even in the absence of classic dysentery symptoms 2, 3.

Tertiary Finding: Possible Urinary Tract Infection

The urinalysis shows:

• 27 pus cells
• 10 RBCs
• 728 bacteria
• 2+ protein

However, with 44 epithelial cells, this specimen is likely contaminated. The absence of nitrites and leukocyte esterase on dipstick, combined with low inflammatory markers, suggests this is not a true UTI. Obtain a clean-catch or catheterized specimen for repeat urinalysis and culture before treating.

Critical Management Errors to Address

STOP the current antibiotic regimen immediately. Ceftazidime and amikacin are inappropriate for this clinical scenario:

1. No evidence of bacterial infection: Procalcitonin 0.12 and CRP <5.0 rule out bacterial sepsis 1
2. Normal white blood cell count (6.58) with neutrophil predominance but no left shift
3. Typhoid testing negative: No indication for empiric treatment of enteric fever 1, 5
4. These antibiotics do not cover amebiasis and are unnecessarily broad-spectrum

The 2017 IDSA guidelines explicitly state that empiric antibiotics for diarrhea are not recommended in immunocompetent patients unless there is bloody diarrhea with fever and signs of bacillary dysentery, or signs of sepsis 1, 5. This patient has neither.

Immediate Workup Required

Priority laboratory tests:

1. Hepatitis E IgM and IgG (most likely missed viral cause)
2. EBV VCA IgM and IgG, CMV IgM and IgG (common in adolescents)
3. Repeat clean-catch urinalysis and urine culture (to clarify UTI)
4. Dengue NS1 antigen or PCR if available (to definitively rule out acute dengue)
5. Abdominal ultrasound to evaluate for hepatomegaly, liver abscess, or biliary pathology 3
6. Coagulation studies (PT/INR) to assess synthetic liver function

Monitor closely:

• Daily transaminases and bilirubin
• Albumin and coagulation studies (current albumin 2.3 is low, suggesting synthetic dysfunction)
• Mental status (watch for hepatic encephalopathy)
• Platelet count (currently 115, borderline low)

Recommended Treatment Plan

Immediate actions:

1. Discontinue ceftazidime and amikacin
2. Start metronidazole 500 mg PO/IV three times daily for documented amebiasis 3
3. Continue IV hydration with D5 0.3 NaCl (appropriate for maintenance)
4. Supportive care for hepatitis (no specific antiviral unless hepatitis E confirmed)
5. Hold all hepatotoxic medications including paracetamol

After 7-10 days of metronidazole:

• Add paromomycin 30 mg/kg/day in three divided doses for 7 days as luminal agent 3, 4

If repeat urinalysis confirms UTI:

• Treat with appropriate narrow-spectrum antibiotic based on culture results
• For empiric coverage in adolescent female: consider nitrofurantoin or trimethoprim-sulfamethoxazole

Differential Diagnoses to Consider

Primary hepatitis causes (in order of likelihood):

1. Hepatitis E (most common cause of acute hepatitis in developing countries, not yet tested)
2. EBV or CMV hepatitis (common in adolescents)
3. Drug-induced liver injury (paracetamol, though timing and dosing less suggestive)
4. Autoimmune hepatitis (less likely given acute presentation)
5. Wilson's disease (rare but consider if no viral cause found)

For the diarrhea:

1. Viral gastroenteritis (most common, self-limited)
2. Intestinal amebiasis (documented, requires treatment)
3. Bacterial enteritis (less likely given negative typhoid, low inflammatory markers)

Common Pitfalls to Avoid

1. Do not continue broad-spectrum antibiotics without clear indication - this promotes resistance and provides no benefit 1
2. Do not assume contaminated urine is a UTI - the high epithelial cell count suggests poor collection technique
3. Do not overlook hepatitis E - it's a common cause of acute hepatitis that's often not tested
4. Do not forget the luminal agent after metronidazole - this prevents amebic cyst carriage and relapse 3, 4
5. Do not attribute all findings to a single diagnosis - this patient has multiple concurrent issues

Prognosis and Monitoring

With appropriate treatment, prognosis is excellent:

• Amebiasis responds well to metronidazole with >90% cure rate 3, 4
• Most acute viral hepatitis resolves spontaneously
• Monitor for signs of acute liver failure (coagulopathy, encephalopathy, worsening synthetic function)

Discharge criteria:

• Afebrile for 48 hours
• Tolerating oral intake
• Downtrending transaminases
• No signs of hepatic decompensation
• Completed or transitioned to oral antibiotics if UTI confirmed

Follow-up:

• Repeat liver function tests in 1-2 weeks
• Ensure completion of full amebiasis treatment course
• Stool testing for clearance is not routinely needed unless patient is a food handler or healthcare worker 5